Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome

Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome Publisher

Jamilian M¹ ; Foroozanfard F² ; Mirhosseini N³ ; Kavossian E² ; Aghadavod E⁴ ; Bahmani F⁴ ; Ostadmohammadi V⁴ ; Kia M⁵ ; Eftekhar T⁶ ; Ayati E^{6, 7} ; Mahdavinia M⁸ ; Asemi Z⁴

Show Affiliations

1. Traditional and Complementary Medicine Research Center, Arak University of Medical Sciences, Arak, Iran
2. Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, Iran
3. School of Public Health, University of Saskatchewan, Saskatoon, SK, Canada
4. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Kashan University of Medical Sciences, Kashan, Iran
5. Department of Midwifery, Gorgan Branch, Islamic Azad University, Gorgan, Iran
6. Reproductive Health Research Center, Tehran University of Medical Science, Tehran, Iran
7. Department of Gynecology and Obstetrics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
8. Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: Frontiers in Endocrinology Published:2019

Abstract

Purpose: The aim of the current study was to evaluate the effect of melatonin administration on clinical, hormonal, inflammatory, and genetic parameters in women with polycystic ovarian syndrome (PCOS). Methods: The present randomized, double-blinded, placebo-controlled clinical trial was conducted among 56 patients with PCOS, aged 18–40 years old. Subjects were randomly allocated to take either 5 mg melatonin supplements (n = 28) or placebo (n = 28) twice a day for 12 weeks. Results: Melatonin administration significantly reduced hirsutism (β −0.47; 95% CI, −0.86, −0.09; P = 0.01), serum total testosterone (β −0.11 ng/mL; 95% CI, −0.21, −0.02; P = 0.01), high-sensitivity C-reactive protein (hs-CRP) (β −0.61 mg/L; 95% CI, −0.95, −0.26; P = 0.001), and plasma malondialdehyde (MDA) levels (β −0.25 μmol/L; 95% CI, −0.38, −0.11; P < 0.001), and significantly increased plasma total antioxidant capacity (TAC) levels (β 106.07 mmol/L; 95% CI, 62.87, 149.28; P < 0.001) and total glutathione (GSH) (β 81.05 μmol/L; 95% CI, 36.08, 126.03; P = 0.001) compared with the placebo. Moreover, melatonin supplementation downregulated gene expression of interleukin-1 (IL-1) (P = 0.03) and tumor necrosis factor alpha (TNF-α) (P = 0.01) compared with the placebo. Conclusions: Overall, melatonin administration for 12 weeks to women with PCOS significantly reduced hirsutism, total testosterone, hs-CRP, and MDA, while increasing TAC and GSH levels. In addition, melatonin administration reduced gene expression of IL-1 and TNF-α. Copyright © 2019 Jamilian, Foroozanfard, Mirhosseini, Kavossian, Aghadavod, Bahmani, Ostadmohammadi, Kia, Eftekhar, Ayati, Mahdavinia and Asemi.

Related Docs

View other Related Docs

1. Carnitine and Chromium Co-Supplementation Affects Mental Health, Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome, Journal of Psychosomatic Obstetrics and Gynecology (2019)

2. The Effects of Melatonin Supplementation on Mental Health, Metabolic and Genetic Profiles in Patients Under Methadone Maintenance Treatment, Addiction Biology (2019)

3. The Role of Melatonin in Polycystic Ovary Syndrome: A Review, International Journal of Reproductive BioMedicine (2019)

4. Melatonin Supplementation and the Effects on Clinical and Metabolic Status in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Trial, Clinical Neurology and Neurosurgery (2020)

5. Effects of Melatonin Supplementation on Oxidative Stress: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Hormone Molecular Biology and Clinical Investigation (2020)

6. The Effects of Chromium Supplementation on Endocrine Profiles, Biomarkers of Inflammation, and Oxidative Stress in Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial, Biological Trace Element Research (2016)

7. The Effects of Melatonin Supplementation on Parameters of Mental Health, Glycemic Control, Markers of Cardiometabolic Risk, and Oxidative Stress in Diabetic Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial, Journal of Renal Nutrition (2020)

8. The Influences of Vitamin D and Omega-3 Co-Supplementation on Clinical, Metabolic and Genetic Parameters in Women With Polycystic Ovary Syndrome, Journal of Affective Disorders (2018)

Experts (# of related papers)

View all Related Experts

Mohammad Ali Mansournia (10)

Ahmad Esmaillzadeh (8)

Style	Citing Format
MLA	Jamilian M, et al.. "Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome." Frontiers in Endocrinology, vol. 10, no. MAY, 2019, pp. -.
APA	Jamilian M, Foroozanfard F, Mirhosseini N, Kavossian E, Aghadavod E, Bahmani F, Ostadmohammadi V, Kia M, Eftekhar T, Ayati E, Mahdavinia M, Asemi Z (2019). Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology, 10(MAY), -.
Chicago	Jamilian M, Foroozanfard F, Mirhosseini N, Kavossian E, Aghadavod E, Bahmani F, Ostadmohammadi V, et al.. "Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome." Frontiers in Endocrinology 10, no. MAY (2019): -.
Harvard	Jamilian M et al. (2019) 'Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome', Frontiers in Endocrinology, 10(MAY), pp. -.
Vancouver	Jamilian M, Foroozanfard F, Mirhosseini N, Kavossian E, Aghadavod E, Bahmani F, et al.. Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome. Frontiers in Endocrinology. 2019;10(MAY):-.
BibTex	@article{ author = {Jamilian M and Foroozanfard F and Mirhosseini N and Kavossian E and Aghadavod E and Bahmani F and Ostadmohammadi V and Kia M and Eftekhar T and Ayati E and Mahdavinia M and Asemi Z}, title = {Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome}, journal = {Frontiers in Endocrinology}, volume = {10}, number = {MAY}, pages = {-}, year = {2019} }
RIS	TY - JOUR AU - Jamilian M AU - Foroozanfard F AU - Mirhosseini N AU - Kavossian E AU - Aghadavod E AU - Bahmani F AU - Ostadmohammadi V AU - Kia M AU - Eftekhar T AU - Ayati E AU - Mahdavinia M AU - Asemi Z TI - Effects of Melatonin Supplementation on Hormonal, Inflammatory, Genetic, and Oxidative Stress Parameters in Women With Polycystic Ovary Syndrome JO - Frontiers in Endocrinology VL - 10 IS - MAY SP - EP - PY - 2019 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract